Miltiadis Paliouras

Research

Covid-19 Plasmonic Pcr Point-Of-Care Device Rt-Qpcr Bionanofluid Imaging Pmsa Prostate Cancer

Latest papers

Label-free wide-field imaging of brain tumors using near-infrared endogenous fluorescence and reflectance normalization.
Journal of biomedical optics · 2026
The development of aptamer-functionalized streptavidin magnetic particles for sample purification of SARS-CoV-2 coupled with rapid plasmonic RT-qPCR to improve detection sensitivity.
Analytical methods : advancing methods and applications · 2026
Performance and functional assessment of the Kimera P-IV point-of-care plasmonic qPCR prototype for ultra rapid pathogen detection of chlamydia trachomatis.
Epidemiology and infection · 2025

All 25 publications

Latest funding

Plasmonic PCR for point of care diagnostics
NSERC · 2022 · Co-investigator
$229,950
Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.
CIHR · 2020 · Principal investigator
$717,700
Using a novel androgen receptor knock-in mouse model to investigate defects in circadian rhythm linked to the development Metabolic Syndrome.
CIHR · 2018 · Co-investigator
$772,650

All 7 grants and awards

25 publications.

01

Label-free wide-field imaging of brain tumors using near-infrared endogenous fluorescence and reflectance normalization.

Beaudoin G, Blanquez-Yeste V, Dallaire F, Lee SS, Cayrol R, Guiot MC, Trifiro MA, Paliouras M, Petrecca K, Leblond F

Journal of biomedical optics2026

DOI: 10.1117/1.jbo.31.8.086005 PMID: 42592302

02

The development of aptamer-functionalized streptavidin magnetic particles for sample purification of SARS-CoV-2 coupled with rapid plasmonic RT-qPCR to improve detection sensitivity.

Hayes J, Resendes A, Lee SS, Yousefi M, Vidal S, Paliouras M, Trifiro M

Analytical methods : advancing methods and applications2026

DOI: 10.1039/d6ay00498a PMID: 42299930

03

Performance and functional assessment of the Kimera P-IV point-of-care plasmonic qPCR prototype for ultra rapid pathogen detection of chlamydia trachomatis.

Hayes J, Lee SS, Carnevale J, Shamir D, Bohbot M, Kirk AG, Paliouras M, Trifiro MA

Epidemiology and infection2025

DOI: 10.1017/s0950268825000081 PMID: 39881625

04

Assessing Different PCR Master Mixes for Ultrarapid DNA Amplification: Important Analytical Parameters.

Brukner I, Paliouras M, Trifiro M, Bohbot M, Shamir D, Kirk AG

Diagnostics (Basel, Switzerland)2024

DOI: 10.3390/diagnostics14050477 PMID: 38472949

05

Enhancing in vitro photothermal therapy using plasmonic gold nanorod decorated multiwalled carbon nanotubes.

Oudjedi F, Lee SS, Paliouras M, Trifiro M, Kirk AG

Biomedical optics express2023

DOI: 10.1364/boe.504746 PMID: 38420328

06

Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer.

Seltzer S, Giannopoulos PN, Bismar TA, Trifiro M, Paliouras M

Asian journal of andrology2023Senior author

DOI: 10.4103/aja202263 PMID: 36259569

07

Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology.

Lee SS, Paliouras M, Trifiro MA

Bioengineering (Basel, Switzerland)2023

DOI: 10.3390/bioengineering10010108 PMID: 36671680

08

Plasmonic and label-free real-time quantitative PCR for point-of-care diagnostics.

Mohammadyousef P, Paliouras M, Trifiro MA, Kirk AG

The Analyst2021

DOI: 10.1039/d0an02496a PMID: 34378560

09

Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.

Sharif-Askari B, Doyon D, Paliouras M, Aloyz R

Scientific reports2019

DOI: 10.1038/s41598-019-47305-2 PMID: 31363127

10

Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate development.

Nash C, Boufaied N, Badescu D, Wang YC, Paliouras M, Trifiro M, Ragoussis I, Thomson AA

Disease models & mechanisms2019

DOI: 10.1242/dmm.039297 PMID: 31350272

Plasmonic PCR for point of care diagnostics

Co-investigatorNSERC2022Alliance Grants

Principal investigators: Kirk, Andrew AK

Keywords: aptamers; DNA; fluorescence; microfluidics; molecular diagnostics; optoelectronics; plasmonics; polymerase chain reaction; RNA; thermal management

$229,950

Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.

Principal investigatorCIHR2020Operating Grant: COVID-19 - Diagnostics

Principal investigators: Trifiro, Mark A; Kirk, Andrew; Paliouras, Miltiadis

Keywords: Covid-19; Plasmonic Pcr; Point-Of-Care Device; Rt-Qpcr

$717,700

Using a novel androgen receptor knock-in mouse model to investigate defects in circadian rhythm linked to the development Metabolic Syndrome.

Co-investigatorCIHR2018Project Grant

Principal investigators: Trifiro, Mark A; Amir, Shimon

Keywords: Androgen Receptor; Circadian Rhythm; Clock Genes; Fatty Liver Disease; Mouse Model; Nash

$772,650

Ultra-fast High Throughput Digital PCR Platform: Redefining Point-of-Care Diagnostics

Co-investigatorCIHR2016Operating Grant: Antimicrobial Resistance - EOI

Principal investigators: Trifiro, Mark A

Keywords: Nanoheaters; Plasmonic Pcr; Point-Of-Care; Ultra-Fast

$2,250

Targeting novel BioNanofluids for prostate cancer therapy

Principal investigatorCIHR2014Proof of Principle Program - Phase I

Principal investigators: Trifiro, Mark A; Paliouras, Miltiadis

Keywords: Bionanofluid; Imaging; Pmsa; Prostate Cancer; Targeted Therapy; Xenotransplant

$148,240

Innovative Approaches to Functional Characterization of the Androgen Receptor in Prostate Cancer

Co-investigatorCIHR2010Operating Grant

Principal investigators: Trifiro, Mark A

Keywords: Androgen Receptor; Dna Methylation; Exon Arrays; Gene Expression; Prostate Cancer; Proteomics; Rna Splicing; Somatic Mutations; Systems Biology

$560,279

Prostate cancer: Somatic genetics and novel therapeutics

Co-investigatorCIHR2008Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients - LOI

Principal investigators: Trifiro, Mark A; Corcos, Jacques; Purisima, Enrico O; Schirrmacher, Esther; Wang, Edwin

Keywords: Animal Models; Prostate Cancer; Protein Structure And Function; Somatic Genetics; Systems Biology; Therapeutics

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Lady Davis Institute for Medical Research
Engineering Physics
Neurology and Neurosurgery
Human Genetics
Other

Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Ivan Brukner

Lady Davis Institute for Medical Research

1 shared papers, latest 2024

Kevin Petrecca

Neurology and Neurosurgery

1 shared papers, latest 2026

Silvia Vidal

Human Genetics

1 shared papers, latest 2026

Kevin Petrecca

Engineering Physics

1 shared papers, latest 2026

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2020

Subject: Prospective PhD student: Covid-19 Dear Professor Paliouras, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Label-free wide-field imaging of brain tumors using near-infrared endogenous fluorescence and reflectance normalization." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform." (2020), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Miltiadis Paliouras

Research

Latest papers

Latest funding

Label-free wide-field imaging of brain tumors using near-infrared endogenous fluorescence and reflectance normalization.

The development of aptamer-functionalized streptavidin magnetic particles for sample purification of SARS-CoV-2 coupled with rapid plasmonic RT-qPCR to improve detection sensitivity.

Performance and functional assessment of the Kimera P-IV point-of-care plasmonic qPCR prototype for ultra rapid pathogen detection of chlamydia trachomatis.

Assessing Different PCR Master Mixes for Ultrarapid DNA Amplification: Important Analytical Parameters.

Enhancing in vitro photothermal therapy using plasmonic gold nanorod decorated multiwalled carbon nanotubes.

Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer.

Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology.

Plasmonic and label-free real-time quantitative PCR for point-of-care diagnostics.

Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.

Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate development.

Plasmonic PCR for point of care diagnostics

Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.

Using a novel androgen receptor knock-in mouse model to investigate defects in circadian rhythm linked to the development Metabolic Syndrome.

Ultra-fast High Throughput Digital PCR Platform: Redefining Point-of-Care Diagnostics

Targeting novel BioNanofluids for prostate cancer therapy

Innovative Approaches to Functional Characterization of the Androgen Receptor in Prostate Cancer

Prostate cancer: Somatic genetics and novel therapeutics

Frequent collaborators

Mark Trifiro

Ivan Brukner

Kevin Petrecca

Thierry Muanza

Ioannis Ragoussis

Silvia Vidal

Kevin Petrecca